Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00549445 · ClinicalTrials.gov registry record
Effect of Macrolide Antibiotics on Airway Inflammation in People With Chronic Obstructive Pulmonary Disease (COPD)
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 53
- Enrollment target
NCT00549445 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 53 participants.
The verdict
NCT00549445 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
Chronic obstructive pulmonary disease (COPD) is a chronic lung disease. Azithromycin, an antibiotic, may be beneficial at reducing the symptoms and severity of the disease. This study will analyze previously collected study data to evaluate the anti-inflammatory properties of azithromycin and determine how azithromycin affects the frequency and severity of COPD exacerbations.
Interventions
- DRUG Placebo
- DRUG Azithromycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00549445
The ClinicalTrials.gov registry entry for NCT00549445 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00549445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00549445 about?
NCT00549445 is a clinical study titled "Effect of Macrolide Antibiotics on Airway Inflammation in People With Chronic Obstructive Pulmonary Disease (COPD)". Chronic obstructive pulmonary disease (COPD) is a chronic lung disease. Azithromycin, an antibiotic, may be beneficial at reducing the symptoms and severity of the disease. This study will analyze previously collected study data to evaluate the anti-inflammatory properties of azithromycin and determ...
What is the current status of trial NCT00549445?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2007-08. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00549445?
The interventions under investigation include: Placebo (DRUG), Azithromycin (DRUG).
Who is sponsoring clinical trial NCT00549445?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.